Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Am J Obstet Gynecol. 2011 Jul 20;205(5):498.e1–498.e6. doi: 10.1016/j.ajog.2011.07.011

Table 2.

Bivariate Analysis of Clinico-demographic Factors Associated with S/AE within 24 months

Factors OR (95% CI)* p-value* P-value**
Treatment group 0.003
 Retropubic vs. Transobturator 1.63 ( 1.18--2.26)

Age (per 10 year interval) 1.01 (0.87, 1.17) 0.88 0.83

BMI (per 5 units) 1.12 (0.99, 1.26) 0.08 0.10

Diabetes 0.87 0.73
 Yes vs. No (ref) 1.05 ( 0.55--2.03)

Prior UI surgery 0.005 0.004
 Yes vs. No (ref) 1.99 ( 1.23--3.22)

Prior POP surgery 0.051 0.04
 Yes vs. No (ref) 0.37 ( 0.13--1.01)

Previous Hysterectomy Surgery 0.07 0.052
 Yes vs. No (ref) 0.71 ( 0.49--1.03)

Concomitant surgery 0.25 0.23
 Yes vs. No (ref) 1.24 ( 0.86--1.80)

Operative time (per 30 min interval) 1.23 (1.09, 1.37) <0.001 <0.001

Blood loss - Entire case (per 50 cc) 1.24 (1.11, 1.39) <0.001 <0.001
  - Mid-urethral sling (per 50 cc) 1.82 (1.40, 2.37) <0.0001 <0.0001

POP-Q stage 0.87 0.87
 Stage 0/1 vs. Stage 3/4 0.87 ( 0.47--1.61)
 Stage 2 vs. Stage 3/4 0.85 ( 0.46--1.57)

History of UTI 0.009 0.005
 Yes vs. No (ref) 2.37 ( 1.24--4.52)

Smoking 0.97 0.93
 Never Smoker vs. Current smoker (ref) 1.05 ( 0.64--1.72)
 Former smoker vs. Current smoker (ref) 1.07 ( 0.63--1.81)

Menopausal status/HRT 0.56 0.57
 No vs. Pre-Menopausal (ref) 1.21 ( 0.82--1.79)
 Yes vs. Pre-Menopausal (ref) 1.23 ( 0.80--1.88)
*

Unadjusted

**

Adjusted for treatment